# Carter BloodCare - Tyler – FDA Inspection, Jun 1, 2016

Source: https://www.keypedia.com/records/fda_inspections/carter-bloodcare-tyler/ce943196-1cb0-49c1-a00d-65431596f973
Source feed: FDA_Inspections

> FDA inspection 974966 of Carter BloodCare - Tyler, June 01, 2016. Classification: Voluntary Action Indicated (VAI). 3 citations under 21 CFR part 606. 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 974966
- Company Name: Carter BloodCare - Tyler
- Inspection Date: 2016-06-01
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 3

## Related Documents

- FDA Inspection 1264020 - 2025-03-07
- FDA Inspection 1173367 - 2022-06-16
- FDA Inspection 1041185 - 2018-02-02
- FDA Inspection 883573 - 2014-06-06
- FDA Inspection 764424 - 2012-01-20

Company: https://www.keypedia.com/companies/carter-bloodcare-tyler/dc81e28f-3ee5-4b46-92ec-04901dd3199b

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
